top of page
Session One
Session Two
Session Three
1:30 - 2:00 Lunch Time Dialog: U.S. - China Relationship:
Where Shall We Go?
4:15 - 5:15 Round Table: Future Public Health & Healthcare in China
Jing Wu
Director,
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention

Qingyu Kong
Vice President, Beijing Anzhen Hospital, Capital Medical University

Tao Hong
Vice President, 1st Teaching Hospital, Nanchang University
Session Six
5:15 - 6:15 Round Table: Future Public Health & Healthcare in the U.S.

Arlene Bierman
Director of Center for Evidence and Practice Improvement (CEPI), Agency for Healthcare Research and Quality (AHRQ), U.S. DHHS

Alfred Demaria
Former State Epidemiologist for Massachusetts and former Medical Director of the Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health

Marc-David Munk
Former Chief Medical Officer, CVS Minute Clinic

Joe Kimura
CMO,
Atrius Health

Christine Lu
Associate Professor & Co-director, PRecisiOn Medicine Translational Research (PROMoTeR) Center, Department of Population Medicine, HMS & HPHCI
6:15 - 6:30 Closing Remarks
6:30 - 8:00 Social Time
6:30 - 7:00 Cocktail Social
Sep 26, 2019
Health Care Innovation & Investment Forum
Opening Remarks
Opening Remarks
8:00 - 8:30

Stephen Kennedy Smith
Principal and Board Member, Park Agency Enterprises, Kennedy Family Office
Sep 27, 2019
Building a Sustainable Health Care System
8:00 - 10:00 Health Without Boarders - Learning & Collaborating Under The Global Lens
Yuanli Liu
Dean, School of Public Health, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC)

Daniel Tsai
Assistant Secretary for MassHealth and Medicaid Director for the Commonwealth
Richard Platt
Professor and Chair,
Department of Population Medicine
Lincoln C. Chen
President,
China Medical Board
10:00 - 10:30 Coffee Break
Session One
8:30 - 9:00 Keynote
Geroge M. Church
Professor of Genetics, Harvard Medical School
9:00 - 10:00 Panel: New Frontier in Precision Medicine
Alex Wu
Partner, Green Pine Captal Partners

10:00 - 10:15 Coffee Break
10:15 - 11:15 Showcase: Cell and Gene Therapy

Michael Fenn
Director, Healthcare & Life Science, Harvard Innovation Lab
Special Dialog
11:15 - 12:15 IP Protection in U.S. & China

Jeffrey J. Ellison
Ph.D., Partner, Clark+Elbing
.jpeg)
Can Cui
Ph.D., Associate, Morrison Foerster

Jonathan Darrow
Faculty Program on Regulation, Therapeutics & Law, Harvard Medical School
12:30 - 2:00 FDA Regulation in U.S. & China
3:45 - 4:15 Keynote

Corey McCann
Founder and CEO, Pear Therapeutics
4:15 - 5:15 Panel: How Digital Health is Transforming Healthcare
5:15 - 6:15 Showcase: Digital Health Technology is Transforming Healthcare Delivery

Rick Williams
Former President,
Boston Harvard Business School Alumni Association;
Managing Director,
Williams Advisory Partners

Ezra Vogel
Henry Ford II Professor of the Social Sciences Emeritus, Harvard University
Special Lunch Dialog
Session Two
2:00 - 2:30 Keynote
Rushika Fernandopulle
Co-founder and CEO, Iora Health
2:30 - 3:30 Panel: Who Pays for Innovation?


3:30 - 3:45 Coffee Break
Session Three

Mark Wu
Henry L. Stimson Professor,
Harvard Law School
Session Four
2:00 - 4:00 Value-Based Insurance and Healthcare Quality

James Frank Wharam
Chief,
Division of Health Policy & Insurance, Department of Population Medicine (DPM)
Michael Sherman
Chief Medical Officer, Harvard Pilgrim Health Care

Jianqin Gu
President,
Henan Provincial People's Hospital, China

Mark Fendrick
Director,
Value-Based Insurance Design (V-BID) Center, University of Michigan

David Khougazian
Head of Specialty Care for China and Emerging Market, Sanofi
4:00 - 4:15 Coffee Break
Session Five


Yong Xu
President, Shenzhen People's Hospital, China
bottom of page